Nuvana — brand details under validation

Nuvana· Dental

Decisions

Decision log

Investors should see why the strategy exists — and what would change it. Reasoning stays visible instead of buried in chats.

D-001

Working hypothesis

Investor-facing venture room before patient marketing site

Build a living thesis / roadmap / decision surface first. Patient marketing waits until brand and acquisition path are clearer.

Evidence for

  • + Forces clarity on model, capital, and roles
  • + Useful for founder conversations immediately
  • + Avoids premature brand lock-in

Evidence against

  • − Looks less “finished” than a clinic website
  • − Requires discipline to keep content updated

D-002

Working hypothesis

Keep brand name temporary (Nuvana as working label only)

Do not commit capital or legal identity to Nuvana until challengers and clearance complete.

Evidence for

  • + Florida healthcare entities already use Nuvana-adjacent names
  • + Preserves negotiating room on identity
  • + Domain/search ≠ legal availability

Evidence against

  • − Temporary names create mild messaging friction
  • − Mockups already use Nuvana visually

D-003

Accepted for V0.1

Greyscale visual system until identity decisions land

Black / grey / white only so color and brand polish remain open decisions.

Evidence for

  • + Prevents fake finality from colored mockups
  • + Keeps focus on thesis and economics

Evidence against

  • − Less emotional warmth than spa-brand comps

D-004

Working hypothesis

Acquisition-first strategy

Prefer acquiring an existing Orlando practice and transforming it over starting from zero.

Evidence for

  • + Immediate patient base
  • + Existing hygiene revenue
  • + Lower patient-acquisition risk
  • + Faster path to positive cash flow
  • + Financing paths more concrete against cash flow

Evidence against

  • − Higher upfront debt
  • − Inherited staff / system issues
  • − Rebranding risk
  • − Culture and clinical fit may not transfer

D-005

Exploring

Separate clinical ownership from management / technology leverage

Structure for Florida compliance and to keep platform IP from being trapped in one office.

Evidence for

  • + Aligns with Florida nondentist ownership constraints
  • + Protects platform IP via license
  • + Creates a repeatable operating-company story

Evidence against

  • − More legal complexity and cost
  • − Poorly drafted MSAs can still create control problems